Breast cancer research is indeed an effective way to find out more choices to cope with this menace of breast cancer. It requires immense hard work and struggle and as a result a sigh of relief for the patient. Breast cancer screening is the fundamental principle for averting this disease or to treat it well in time.
According to BBC news experts have discovered a new drug which is effective for one in five patients of breast cancer. According to reports, almost 10,000 women in the UK can be benefited from this drug every year. This new treatment is actually the Biological therapies which are operative against the kind of breast cancer which occur due to the rare congenital genetic errors like BRCA. If you have heard about the actress Angelina Jolie having the same kind of breast cancer. Such targeted therapies can be equally useful for those women who do not have a genetic type of breast cancer. The percentage of recovery from these therapies is 20 percent when we talk about the percentage of recovery. This therapy is not yet approved for the treatment of breast cancer though this has already been used for clinical trials in the UK.
Currently, 560 patients were searched for the genetic errors which can cause breast cancer. It was found that a noteworthy proportion of the patients were present with such errors which can also be called “mutational signatures". Doctor Helen Davies, who was part of this research said, “There was also the potential to treat other types of cancers with these drugs”.
Researchers also suggested that more clinical trials are needed to further go into the details so to get more benefits out of it. It would certainly be the greatest advancement in the field of breast cancer research but here it should also be remembered that the breast cancer screening is the only way to get the things done in the right way.